Skip to main content

Table 3 Comparison of initial outcome measures in three subgroups of patients treated with IVIG with different doses

From: The outcome of using intravenous immunoglobulin (IVIG) in critically ill COVID-19 patients’: a retrospective, multi-centric cohort study

Feature

Low-dose IVIG

Medium dose IVIG

High-dose IVIG

p value

Number of patients (%)

25 (33.8)

32 (43.2)

17 (23)

 

ICU length of stay (days)

10.24

9.77

7.94

0.642

Duration of hospitalization (days)

13.12

16.09

10.39

0.050

Duration of mechanical ventilation (days)

24

29

17

0.703

Mortality rate (%)

13 (52)

18 (56.25)

11 (64.70)

0.83

  1. ICU: intensive care unit; IVIG: intravenous immunoglobulin